The formula of the product has been additionally supplemented with L-arginine, L-ornithine, and chromium in the form of a chelated compound, namely picolinate
The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma
Lancet 384(9961):22282234
The microdose schedule can be customized based on individual response
Usage Instructions Inject once weekly under the skin (abdomen, thigh, upper arm) Start at 0.25 mg weekly for 4 weeks, then increase as directed Doses may be raised to 0.5 mg, 1 mg, or 2 mg weekly Use at the same time each week (with or without food) Rotate injection sites to prevent skin irritation Side Effects Nausea, vomiting, diarrhea or constipation Loss of appetite Fatigue or headache Rare: pancreatitis, gallbladder problems, kidney injury, allergic reactions Increased risk of thyroid tumors in animal studies (not seen in humans) Side effects are often mild and improve with time